Exempt Chemical Preparations Under the Controlled Substances Act, 6203 [C1-2022-01112]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 23 / Thursday, February 3, 2022 / Notices
INTERNATIONAL TRADE
COMMISSION
DEPARTMENT OF JUSTICE
[Investigation Nos. 701–TA–528–529 and
731–TA–1264–1268 (Review)]
[Docket No. DEA–372]
Determinations
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
countervailing duty orders on uncoated
paper from China and Indonesia and the
antidumping duty orders on uncoated
paper from Australia, Brazil, China,
Indonesia, and Portugal would be likely
to lead to continuation or recurrence of
material injury to an industry in the
United States within a reasonably
foreseeable time.
Background
khammond on DSKJM1Z7X2PROD with NOTICES
The Commission instituted these
reviews on February 1, 2021 (86 FR
7734) and determined on May 7, 2021,
that it would conduct full reviews (86
FR 27650, May 21, 2021). Notice of the
scheduling of the Commission’s reviews
and of a public hearing to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register on July 23, 2021 (86 FR
39057). The Commission conducted its
hearing on November 18, 2021. All
persons who requested the opportunity
were permitted to participate.
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on January 31, 2022.
The views of the Commission are
contained in USITC Publication 5275
(January 2022), entitled Uncoated Paper
from Australia, Brazil, China, Indonesia,
and Portugal: Investigation Nos. 701–
TA–528–529 and 731–TA–1264–1268
(Review).
By order of the Commission.
Issued: January 31, 2022.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2022–02293 Filed 2–2–22; 8:45 am]
BILLING CODE 7020–02–P
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
VerDate Sep<11>2014
18:08 Feb 02, 2022
Jkt 256001
Exempt Chemical Preparations Under
the Controlled Substances Act
Correction
In Notice document 2022–01112
beginning on page 3335 in the issue of
Friday, January 21, 2022, make the
following correction:
On page 3343, beginning on the last
line of the first column, ‘‘This Order is
effective [insert Date Thirty Days from
the Date of Publication in the Federal
Register].’’ should read ‘‘This Order is
effective February 22, 2022.’’.
[FR Doc. C1–2022–01112 Filed 2–2–22; 8:45 am]
BILLING CODE 0099–10–D
DEPARTMENT OF LABOR
Office of Workers’ Compensation
Programs
Proposed Extension of Existing
Collection; Comment Request
Division of Coal Mine Workers’
Compensation, Office of Workers’
Compensation Programs, Department of
Labor.
ACTION: Notice.
AGENCY:
Currently, the Office of
Workers’ Compensation Programs is
soliciting comments concerning the
proposed collection: Disclosure of
Medical Evidence. A copy of the
proposed information collection request
can be obtained by contacting the office
listed below in the addresses section of
this Notice. This program helps to
ensure that requested data can be
provided in the desired format,
reporting burden (time and financial
resources) is minimized, collection
instruments are clearly understood and
the impact of collection requirements on
respondents can be properly assessed.
DATES: Written comments must be
submitted to the office listed in the
address section below on or before April
4, 2022.
ADDRESSES: You may submit comments
by mail, delivery service, or by hand to
Ms. Anjanette Suggs, U.S. Department of
Labor, 200 Constitution Avenue NW,
Room S–3323, Washington, DC 20210;
by fax to (202) 354–9660; or by Email to
Suggs.Anjanette@dol.gov. Please use
only one method of transmission for
comments (mail/delivery, fax or Email).
Please note that comments submitted
after the comment period will not be
considered.
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
The
Department of Labor, as part of its
continuing effort to reduce paperwork
and respondent burden, conducts a preclearance consultation program to
provide the general public and Federal
agencies with an opportunity to
comment on proposed and/or
continuing collections of information in
accordance with the Paperwork
Reduction Act of 1995 (PRA95).
SUPPLEMENTARY INFORMATION:
Drug Enforcement Administration
Uncoated Paper From Australia, Brazil,
China, Indonesia, and Portugal
6203
I. Background
The Department’s regulations
implementing the Black Lung Benefits
Act (BLBA), 30 U.S.C. 901 et seq., may
require parties to exchange all medical
information about the minter they
develop in connection with a claim for
benefits, including information parties
do not intent to submit as evidence in
the claim. See 20 CFR 725.413. The rule
helps protect a miner’s health, assist
unrepresented parties, and promote
accurate benefit determinations.
The potential parties to a BLBA claim
include the benefits claimant, the
responsible coal mine operator and its
insurance carrier, and the Director,
Office of Workers’ Compensation
Programs (OWCP). Under this rule, a
party of a party’s agent who receives
medical information about the minter
must send a copy to all other parties
within 30 days after receipt or, if a
hearing before an administrative law
judge has already been scheduled, at
least 20 days before the hearing. The
exchanged information is entered into
the record of the claim only if a party
submits it into evidence.
The Department’s authority to engage
in information collection is specified in
BLBA sections 413(b), 422(2) and
426(a). see 30 U.S.C. 923(b), 932(a) and
936(a). This information collection is
currently approved for use through July
31, 2022.
II. Review Focus
The Department of Labor is
particularly interested in comments
which:
* Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
* evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
* enhance the quality, utility and
clarity of the information to be
collected; and
* minimize the burden of the
collection of information on those who
E:\FR\FM\03FEN1.SGM
03FEN1
]]>Agencies
[Federal Register Volume 87, Number 23 (Thursday, February 3, 2022)]
[Notices]
[Page 6203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C1-2022-01112]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-372]
Exempt Chemical Preparations Under the Controlled Substances Act
Correction
In Notice document 2022-01112 beginning on page 3335 in the issue
of Friday, January 21, 2022, make the following correction:
On page 3343, beginning on the last line of the first column,
``This Order is effective [insert Date Thirty Days from the Date of
Publication in the Federal Register].'' should read ``This Order is
effective February 22, 2022.''.
[FR Doc. C1-2022-01112 Filed 2-2-22; 8:45 am]
BILLING CODE 0099-10-D
